Pregnant women and infants are at risk should they contract mpox but there are no approved vaccines for this population.

The registrational trial is expected to support the approval for Bavarian’s mpox/smallpox vaccine use in children between two ...

Russia has claimed that there is an increased interest from African and ex-Soviet countries in its mpox vaccine, Orthopoxvac ...

As cases of Mpox rise abroad, residents in San Mateo County still face barriers to getting vaccinated. This low uptake comes ...

The World Health Organization said on Monday it had approved Bavarian Nordic's mpox vaccine for adolescents aged 12 to 17 years, an age group considered especially vulnerable to outbreaks of the ...

Daphne Von Buxhoeveden from the EU’s Health Emergency Preparedness and Response Authority said Wednesday she expected 100,000 ...

An initial 899,000 vaccine doses have been allocated for 9 countries across Africa that have been hit hard by the current ...

To safeguard against additional cases, either at home or while deployed, the Defense Health Agency and the services have made ...

Johnson & Johnson has halved the size of its collaboration with Bavarian Nordic on vaccine development, jettisoning its stake in shots targeting human papillomavirus (HPV) and hepatitis B virus (HBV).

WHO says the vaccines will go to the Central African Republic, Ivory Coast, the Democratic Republic of Congo, Kenya, Liberia, ...

Bavarian Nordic is looking to expand the approval label of its MVA-BN mpox/smallpox vaccine to include children between two and 11 years of age and has started a Phase II trial to support the ...